Drug products: ZYTIGA
ATC code: L02BX03
Substances: abiraterone, abiraterone acetate
As the substance is only used by men, analyses on sex or gender differences have not been considered relevant.
Abiraterone is an inhibitor of 17 alpha-hydroxylase/C17,20-lyase (CYP17) that blocks androgen biosynthesis . The approved indication for abiraterone in combination with methylprednisolone or prednisone is treatment of certain types of prostate cancer .
Date of litterature search: 2018-12-06
Reviewed by: Karin Schenck-Gustafsson
Approved by: Karin Schenck-Gustafsson